- Home
- SEAT vs HUMA Comparison
SEAT vs HUMA Comparison
Compare SEAT & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEAT
- HUMA
- Stock Information
- Founded
- SEAT 2001
- HUMA 2004
- Country
- SEAT United States
- HUMA United States
- Employees
- SEAT N/A
- HUMA N/A
- Industry
- SEAT Industrial Machinery/Components
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- SEAT Industrials
- HUMA Health Care
- Exchange
- SEAT Nasdaq
- HUMA Nasdaq
- Market Cap
- SEAT 622.1M
- HUMA 584.8M
- IPO Year
- SEAT N/A
- HUMA N/A
- Fundamental
- Price
- SEAT $4.58
- HUMA $4.59
- Analyst Decision
- SEAT Strong Buy
- HUMA Strong Buy
- Analyst Count
- SEAT 10
- HUMA 7
- Target Price
- SEAT $6.73
- HUMA $13.43
- AVG Volume (30 Days)
- SEAT 1.3M
- HUMA 8.0M
- Earning Date
- SEAT 03-04-2025
- HUMA 11-08-2024
- Dividend Yield
- SEAT N/A
- HUMA N/A
- EPS Growth
- SEAT N/A
- HUMA N/A
- EPS
- SEAT N/A
- HUMA N/A
- Revenue
- SEAT $774,076,000.00
- HUMA N/A
- Revenue This Year
- SEAT $10.17
- HUMA N/A
- Revenue Next Year
- SEAT $4.02
- HUMA $5,584.53
- P/E Ratio
- SEAT N/A
- HUMA N/A
- Revenue Growth
- SEAT 13.91
- HUMA N/A
- 52 Week Low
- SEAT $3.24
- HUMA $2.80
- 52 Week High
- SEAT $6.41
- HUMA $9.97
- Technical
- Relative Strength Index (RSI)
- SEAT 59.60
- HUMA 49.66
- Support Level
- SEAT $4.30
- HUMA $4.30
- Resistance Level
- SEAT $5.00
- HUMA $4.67
- Average True Range (ATR)
- SEAT 0.23
- HUMA 0.35
- MACD
- SEAT 0.01
- HUMA -0.03
- Stochastic Oscillator
- SEAT 40.00
- HUMA 39.04
About SEAT Vivid Seats Inc.
Vivid Seats Inc is an online ticket marketplace for connecting fans to live events and artists. It is the official ticketing partner of brands in the entertainment industry providing tickets for sports, concerts, theatres, and comedy events in the United States, Canada and Japan. It operates in two segments namely marketplace and resale.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.